We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Stockbroker tips from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Citi upgrades Phoenix Group to 'buy' from 'neutral'

Wed 21 May 2025 10:26

(Sharecast News) - Citi upgraded Phoenix Group on Wednesday to 'buy' from 'neutral' and lifted the price targe to 730p from 537p as it pointed to balance sheet flexibility and a growing franchise.

Broker tips: Babcock, Phoenix Group

Wed 21 May 2025 07:44

(Sharecast News) - JPMorgan Cazenove lifted its price target on Babcock on Wednesday to 1,100p from 1,000p as it said the next five years are looking "very exciting".

RBC Capital ups price target on Hikma

Tue 20 May 2025 13:14

(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.

Berenberg starts coverage of Accesso Technology at 'buy'

Tue 20 May 2025 11:23

(Sharecast News) - Berenberg initiated coverage of Accesso Technology on Tuesday with a 'buy' rating and 775p price target.

Barclays downgrades B&Q owner Kingfisher

Tue 20 May 2025 10:03

(Sharecast News) - Barclays downgraded its stance on B&Q and Castorama owner Kingfisher on Tuesday to 'underweight' from 'equalweight' as it said the more than 25% year-to-date total shareholder return was "overly generous".

Broker tips: Kingfisher, Accesso, Hikma

Tue 20 May 2025 07:34

(Sharecast News) - Barclays downgraded its stance on B&Q and Castorama owner Kingfisher on Tuesday to 'underweight' from 'equalweight' as it said the more than 25% year-to-date total shareholder return was "overly generous".

Dr Martens consensus estimates may be too optimistic, says RBC Capital

Mon 19 May 2025 11:01

(Sharecast News) - RBC Capital Markets cut its price target on Dr Martens on Monday to 60p form 70p and reduced its revenue and earnings per share estimates, saying that consensus estimates may be too optimistic.

Jefferies downgrades BP to 'hold', slashes price target

Mon 19 May 2025 10:26

(Sharecast News) - Jefferies downgraded BP on Monday to 'hold' from 'buy' and slashed the price target to 390p from 550p.

RBC Capital cuts DCC price target

Mon 19 May 2025 09:49

(Sharecast News) - RBC Capital Markets cut its price target on DCC on Monday to 5,200p from 5,400p as it tweaked forecasts to reflect a lower valuation for DCC Technology, given weaker trading and macro uncertainty.

Broker tips: Dr Martens, BP, DCC

Mon 19 May 2025 07:25

(Sharecast News) - RBC Capital Markets cut its price target on Dr Martens on Monday to 60p form 70p and reduced its revenue and earnings per share estimates, saying that consensus estimates may be too optimistic.